George Demos admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the ...

A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., is the latest biopharma executive to plead guilty to insider trading charges. BioWorld ...

George Demos, then-vice president at Acadia Pharmaceuticals, pleaded guilty to illegally selling 60,000 company shares, avoiding a $1.3 million loss by acting on insider knowledge about the labeling ...

The Pittsburgh Steelers' acquisition of star receiver DK Metcalf from the Seattle Seahawks on Sunday reportedly could have significant ramifications for fellow wideout George Pickens. The Athletic ...

The Pittsburgh Steelers have two strong personalities in the wide receiver room in George Pickens and DK Metcalf, and it sounds like they do not plan to move Pickens. Fox Sports insider Jordan ...

A Securities and Exchange Commission proposal requiring digital asset exchanges to register under alternative trading system ...